Theratechnologies Recommendation mean
What is the Recommendation mean of Theratechnologies?
The Recommendation mean of Theratechnologies, Inc. is 2.60
What is the definition of Recommendation mean?
Recommendation mean is the mean of analysts’ ratings of the stock ranging from 1.0 (strong buy) to 5.0 (strong sell).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Recommendation mean of companies in the Health Care sector on TSX compared to Theratechnologies
What does Theratechnologies do?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Companies with recommendation mean similar to Theratechnologies
- HD Supply Inc has Recommendation mean of 2.57
- Jounce Therapeutics Inc has Recommendation mean of 2.57
- U.S. Bancorp has Recommendation mean of 2.58
- HF Sinclair has Recommendation mean of 2.58
- Church & Dwight Co has Recommendation mean of 2.58
- HP Inc has Recommendation mean of 2.59
- Theratechnologies has Recommendation mean of 2.60
- Galapagos NV has Recommendation mean of 2.61
- Redfin Corp has Recommendation mean of 2.61
- Texas Instruments has Recommendation mean of 2.61
- Tenaris S.A has Recommendation mean of 2.62
- DaVita Inc has Recommendation mean of 2.62
- Laredo Petroleum has Recommendation mean of 2.62